The TASA Group, a Futuris Brand, Announces Upcoming Webinar

Rhea-AI Summary

Futuris Company (OTC Pink: FTRS) announced an upcoming webinar titled "A Covert Weapon for Litigators" in collaboration with The TASA Group, scheduled for January 18, 2023. The session will focus on duty and standard of care investigations, leveraging Forensic Business Pathology techniques that have achieved a 96% success rate in over 40 cases. Tom Taormina, an experienced consultant and witness, will lead the presentation. The event aims to provide valuable insights for legal professionals.

Positive

• Webinar scheduled for January 18, 2023, aims to enhance legal professionals' understanding of duty and standard of care.
• Forensic Business Pathology techniques used in investigations have a proven 96% success rate in over 40 cases.

Negative

• None.

FAIRFAX, VA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Futuris Company (OTC Pink: FTRS) a Human Capital Management (HCM) company focused on areas such as Staffing, Consulting, and Tech Services, is excited to announce that The TASA Group, in conjunction with consulting and testifying in personal injury, products liability and organizational negligence expert Tom Taormina, will present a one-hour interactive webinar presentation, A Covert Weapon for Litigators, for all legal professionals on January 18^th, 2023 at 3:00 PM EST.

Proving appropriate or negligent standard of care is typically an endless debate and prejudiced opinions. Utilizing the practice of conducting duty and standard of care investigations with the trademarked Forensic Business Pathology techniques has yielded a 96% success rate in more than 40 cases.

Duty of care is determined by finding and citing compelling standards. Standard of care is determined by comparing the defendant’s actions to international standards of quality management.

Tom Taormina is a consulting and testifying witness in personal injury products liability and organizational negligence. He was a member of the team at Mission Control in Houston during the Apollo 13 disaster and recovery.  His experiences during his 14 years at NASA formed the foundation for his ability to rapidly analyze problems and diagnose solutions.  He has over fifty years of experience in manufacturing related industries and has written 14 books.

To register for this webinar, please visit:

https://event.on24.com/wcc/r/4042271/73C18FADD0253BF44C6F91022F328CDC

“We are proud to see the TASA Group continuing to be the best source for witness experts. Not only are their webinars informative, but they also offer CLE credits in various states,” said Kalyan Pathuri, President of Futuris Company.

We encourage shareholders to continually visit our website and social media platforms for updates.

Website: www.futuris.company

Twitter: www.twitter.com/futuriscompany        

About Futuris Company

Futuris is a Human Capital Management (HCM) company focused on Executive Search, Staffing, Consulting services and Tech Services specializing in verticals such as Medical, Accounting/Finance, Information Technology, Recruitment Process Outsourcing (RPO), and Legal. The Company is committed to building a global HCM company through highly targeted and accretive acquisitions and operational efficiencies. For more information, please visit http://futuris.company/.

Contact Information:

Futuris Company
Preya Narain
Email: info.it@futuris.company

FAQ

What is the topic of Futuris Company's webinar on January 18, 2023?

The webinar titled "A Covert Weapon for Litigators" will focus on duty and standard of care investigations.

Who will present the webinar hosted by Futuris Company?

Tom Taormina, a consultant and expert, will lead the webinar.

What is the success rate of the techniques discussed in the webinar?

The Forensic Business Pathology techniques have a 96% success rate in more than 40 cases.

Where can legal professionals register for the webinar by Futuris Company?

Legal professionals can register for the webinar at the link provided in the press release.